Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.30 |
| ▸ | CDK1 | P06493 | 1/20 | 0.30 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.30 |
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.30 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.30 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16924935 | 0.97 | RAB9A (0.32) | RAB9AKDM4ENPC1GLAMAPT | |
| SCHEMBL27979361 | 0.82 | ALDH1A1 (0.35) | RAB9AKDM4ENPC1GLAKMT2A | |
| SCHEMBL2517442 | 0.82 | ALDH1A1 (0.35) | RAB9AKDM4ENPC1GLAKMT2A | |
| SCHEMBL28807262 | 0.82 | ALDH1A1 (0.35) | RAB9AKDM4ENPC1GLAKMT2A | |
| SCHEMBL28180007 | 0.82 | ALDH1A1 (0.35) | RAB9AKDM4ENPC1GLAKMT2A | |
| SCHEMBL14562749 | 0.82 | ALDH1A1 (0.35) | RAB9AKDM4ENPC1GLAKMT2A | |
| SCHEMBL7996476 | 0.82 | ALDH1A1 (0.35) | RAB9AKDM4ENPC1GLAKMT2A | |
| SCHEMBL17366426 | 0.81 | GCGR (0.41) | MAPTNPY5R | |
| Trimethylammonium SCHEMBL8994460 | 0.77 | GSK3B (0.35) | RAB9ANPC1KMT2AGSK3B | |
| SCHEMBL28062944 | 0.77 | ALDH1A1 (0.31) | RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048152-A1 | GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES | KARLSRUHER INSTITUT FUER TECH KOERPERSCHAFT DES OEFFENTLICHEN RECHTS (DE) | 2026-02-19 | — | — | US | claimed |
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | claimed |
| US-20210292353-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-09-23 | — | — | US | claimed |
| EP-3829565-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2021-06-09 | — | — | EP | claimed |
| WO-2020025488-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2020-02-06 | — | — | WO | claimed |
| US-20170112948-A1 | Inorganic-organic hybrid compound | Karlsruher Institut für Technologie (DE) | 2017-04-27 | — | — | US | claimed |
| US-8480928-B2 | Inorganic-organic composite luminophore | KARLSRUHER INSTITUT FUR TECHNOLOGIE (KIT) (DE) | 2013-07-09 | — | — | US | claimed |
| US-20110198538-A1 | INORGANIC-ORGANIC COMPOSITE LUMINOPHORE | Karlsruher Institut for Technologie (KIT) (DE) | 2011-08-18 | — | — | US | claimed |
| US-20260048152-A1 | GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES | KARLSRUHER INSTITUT FUER TECH KOERPERSCHAFT DES OEFFENTLICHEN RECHTS (DE) | 2026-02-19 | — | — | US | disclosed |
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | disclosed |
| US-20210292353-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-09-23 | — | — | US | disclosed |
| EP-3829565-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2021-06-09 | — | — | EP | disclosed |
| EP-3052502-B1 | PHOTOVOLTAIC CONVERSION ELEMENT AND PHOTOVOLTAIC CELL | UNIV HONG KONG (CN) | 2020-06-24 | — | — | EP | disclosed |
| WO-2020025488-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2020-02-06 | — | — | WO | disclosed |
| US-20170112948-A1 | Inorganic-organic hybrid compound | Karlsruher Institut für Technologie (DE) | 2017-04-27 | — | — | US | disclosed |
| US-20170096434-A1 | DERIVATIZED CORROLES AND METALLOCORROLES AND THEIR USE AS IMAGING AND THERAPEUTIC AGENTS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2017-04-06 | — | — | US | disclosed |
| EP-3052502-A1 | PHOTOVOLTAIC CONVERSION ELEMENT AND PHOTOVOLTAIC CELL | The University of Hong Kong (CN) | 2016-08-10 | — | — | EP | disclosed |
| US-9306183-B2 | Photovoltaic conversion element and photovoltaic cell | THE UNIVERSITY OF HONG KONG (HK) | 2016-04-05 | — | — | US | disclosed |
| US-20150090337-A1 | PHOTOVOLTAIC CONVERSION ELEMENT AND PHOTOVOLTAIC CELL | THE UNIVERSITY OF HONG KONG (HK) | 2015-04-02 | — | — | US | disclosed |
| WO-2015043533-A1 | PHOTOVOLTAIC CONVERSION ELEMENT AND PHOTOVOLTAIC CELL | THE UNIVERSITY OF HONG KONG (CN) | 2015-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170096434-A1 | DERIVATIZED CORROLES AND METALLOCORROLES AND THEIR USE AS IMAGING AND THERAPEUTIC AGENTS | MGMT, MEN1, MB | RAB9A 1304/4885KDM4E 1528/4885NPC1 3318/4885 |
| US-20260048152-A1 | GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES | GOT1, RNMT, GNAO1 | RAB9A 407/4885KDM4E 4410/4885NPC1 1582/4885 |
| US-20170112948-A1 | Inorganic-organic hybrid compound | SLCO4C1, SLCO2A1, SLCO1A2 | RAB9A 2617/4885KDM4E 4356/4885NPC1 277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.